These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24508128)

  • 1. The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether.
    Conyers RC; Mazzone JR; Siegler MA; Tripathi AK; Sullivan DJ; Mott BT; Posner GH
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1285-9. PubMed ID: 24508128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters.
    Conyers RC; Mazzone JR; Tripathi AK; Sullivan DJ; Posner GH
    Bioorg Med Chem Lett; 2015 Jan; 25(2):245-8. PubMed ID: 25481079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial chemotherapy: artemisinin-derived dimer carbonates and thiocarbonates.
    Mazzone JR; Conyers RC; Tripathi AK; Sullivan DJ; Posner GH
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2440-3. PubMed ID: 24775306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single, low, oral dose of a 5-carbon-linked trioxane dimer orthoester plus mefloquine cures malaria-infected mice.
    Moon DK; Tripathi A; Sullivan D; Siegler MA; Parkin S; Posner GH
    Bioorg Med Chem Lett; 2011 May; 21(9):2773-5. PubMed ID: 20952197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs.
    Mott BT; Tripathi A; Siegler MA; Moore CD; Sullivan DJ; Posner GH
    J Med Chem; 2013 Mar; 56(6):2630-41. PubMed ID: 23425037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria-infected mice are cured by oral administration of new artemisinin derivatives.
    Posner GH; Chang W; Hess L; Woodard L; Sinishtaj S; Usera AR; Maio W; Rosenthal AS; Kalinda AS; D'Angelo JG; Petersen KS; Stohler R; Chollet J; Santo-Tomas J; Snyder C; Rottmann M; Wittlin S; Brun R; Shapiro TA
    J Med Chem; 2008 Feb; 51(4):1035-42. PubMed ID: 18232653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria-infected mice live until at least day 30 after a new artemisinin-derived thioacetal thiocarbonate combined with mefloquine are administered together in a single, low, oral dose.
    Jacobine AM; Mazzone JR; Slack RD; Tripathi AK; Sullivan DJ; Posner GH
    J Med Chem; 2012 Sep; 55(17):7892-9. PubMed ID: 22891714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria-infected mice live until at least day 30 after a new monomeric trioxane combined with mefloquine are administered together in a single low oral dose.
    Woodard LE; Chang W; Chen X; Liu JO; Shapiro TA; Posner GH
    J Med Chem; 2009 Dec; 52(23):7458-62. PubMed ID: 19586052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria-infected mice are completely cured by one 6 mg/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine.
    Slack RD; Mott BT; Woodard LE; Tripathi A; Sullivan D; Nenortas E; Girdwood SC; Shapiro TA; Posner GH
    J Med Chem; 2012 Jan; 55(1):291-6. PubMed ID: 22128829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria-infected mice are cured by a single dose of novel artemisinin derivatives.
    Posner GH; Paik IH; Chang W; Borstnik K; Sinishtaj S; Rosenthal AS; Shapiro TA
    J Med Chem; 2007 May; 50(10):2516-9. PubMed ID: 17439113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy.
    Posner GH; Paik IH; Sur S; McRiner AJ; Borstnik K; Xie S; Shapiro TA
    J Med Chem; 2003 Mar; 46(6):1060-5. PubMed ID: 12620083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
    Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial Preclinical Drug Development: A Single Oral Dose of A 5-Carbon-linked Trioxane Dimer Plus Mefloquine Cures Malaria-Infected Mice.
    Moon DK; Singhal V; Kumar N; Shapiro TA; Posner GH
    Drug Dev Res; 2009 Jan; 71(1):76-81. PubMed ID: 20686674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
    Shu-Hua X; Utzinger J; Chollet J; Tanner M
    Int J Parasitol; 2006 Jul; 36(8):957-64. PubMed ID: 16750833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells.
    Rosenthal AS; Chen X; Liu JO; West DC; Hergenrother PJ; Shapiro TA; Posner GH
    J Med Chem; 2009 Feb; 52(4):1198-203. PubMed ID: 19186946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria.
    Svensson US; Alin H; Karlsson MO; Bergqvist Y; Ashton M
    Eur J Clin Pharmacol; 2002 Aug; 58(5):339-51. PubMed ID: 12185558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate.
    Magueur G; Crousse B; Charneau S; Grellier P; Bégué JP; Bonnet-Delpon D
    J Med Chem; 2004 May; 47(10):2694-9. PubMed ID: 15115411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an antimalarial synthetic trioxolane drug development candidate.
    Vennerstrom JL; Arbe-Barnes S; Brun R; Charman SA; Chiu FC; Chollet J; Dong Y; Dorn A; Hunziker D; Matile H; McIntosh K; Padmanilayam M; Santo Tomas J; Scheurer C; Scorneaux B; Tang Y; Urwyler H; Wittlin S; Charman WN
    Nature; 2004 Aug; 430(7002):900-4. PubMed ID: 15318224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.